Synopsys: Needham Downgrades to Buy, PT Lowered to $550 from $660.
ByAinvest
Wednesday, Sep 10, 2025 6:46 am ET1min read
SNPS--
Synopsys reported a third-quarter revenue of $1.74 billion, up 14% year-over-year (YoY), but this figure fell short of the expected $1.77 billion. Non-GAAP earnings per diluted share (EPS) came in at $3.39, missing the expected $3.75. The company attributed the underperformance to the integration of Ansys and external challenges, including geopolitical tensions and export control restrictions [3].
The downgrade follows a series of recent changes in analyst ratings and price targets. Stifel recently raised its price target to $650 from $550, citing the merger's potential to become accretive sooner than anticipated. KeyBanc and Piper Sandler also increased their price targets to $660, while Goldman Sachs reiterated its Buy rating with a $700 target [2].
Despite the downgrade, Synopsys remains optimistic about its long-term growth prospects. The company expects full-year 2025 revenue between $7.03 and $7.06 billion, with non-GAAP EPS ranging from $12.76 to $12.80. The integration of Ansys is expected to bring significant synergies, with the combined entity targeting a $31 billion total addressable market [1].
The downgrade by Needham Research & Management highlights the ongoing challenges faced by Synopsys in integrating Ansys and navigating external headwinds. However, the company's strong financial health and diversified geographic exposure continue to support its long-term growth prospects. Investors should closely monitor the upcoming earnings call and the progress of the Ansys integration to gauge the company's future performance.
Synopsys: Needham Downgrades to Buy, PT Lowered to $550 from $660.
Synopsys, Inc. (NASDAQ: SNPS) faced a significant downgrade in its stock outlook on September 9, 2025, as Needham Research & Management downgraded the stock from Overweight to Buy, reducing the price target from $660 to $550. This move comes amid mixed third-quarter results and ongoing integration challenges from the acquisition of Ansys.Synopsys reported a third-quarter revenue of $1.74 billion, up 14% year-over-year (YoY), but this figure fell short of the expected $1.77 billion. Non-GAAP earnings per diluted share (EPS) came in at $3.39, missing the expected $3.75. The company attributed the underperformance to the integration of Ansys and external challenges, including geopolitical tensions and export control restrictions [3].
The downgrade follows a series of recent changes in analyst ratings and price targets. Stifel recently raised its price target to $650 from $550, citing the merger's potential to become accretive sooner than anticipated. KeyBanc and Piper Sandler also increased their price targets to $660, while Goldman Sachs reiterated its Buy rating with a $700 target [2].
Despite the downgrade, Synopsys remains optimistic about its long-term growth prospects. The company expects full-year 2025 revenue between $7.03 and $7.06 billion, with non-GAAP EPS ranging from $12.76 to $12.80. The integration of Ansys is expected to bring significant synergies, with the combined entity targeting a $31 billion total addressable market [1].
The downgrade by Needham Research & Management highlights the ongoing challenges faced by Synopsys in integrating Ansys and navigating external headwinds. However, the company's strong financial health and diversified geographic exposure continue to support its long-term growth prospects. Investors should closely monitor the upcoming earnings call and the progress of the Ansys integration to gauge the company's future performance.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet